Lerato Mohapi

3.7k total citations
35 papers, 1.5k citations indexed

About

Lerato Mohapi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Lerato Mohapi has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 15 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Lerato Mohapi's work include HIV/AIDS Research and Interventions (18 papers), HIV/AIDS drug development and treatment (18 papers) and HIV Research and Treatment (15 papers). Lerato Mohapi is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), HIV/AIDS drug development and treatment (18 papers) and HIV Research and Treatment (15 papers). Lerato Mohapi collaborates with scholars based in South Africa, United States and Thailand. Lerato Mohapi's co-authors include Neil Martinson, Glenda Gray, James McIntyre, Jonathan E. Golub, Richard E. Chaisson, Fatima Laher, Nkeko Tshabangu, Paul Pronyk, Mosa Moshabela and Ziad El‐Khatib and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lerato Mohapi

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lerato Mohapi South Africa	20	1.2k	684	467	218	172	35	1.5k
Bingxia Wang United States	21	1.0k 0.8×	675 1.0×	435 0.9×	194 0.9×	101 0.6×	56	1.6k
Kenneth A. Freedberg United States	10	1.2k 1.0×	714 1.0×	538 1.2×	132 0.6×	137 0.8×	15	1.5k
Prudence Ive South Africa	22	1.7k 1.3×	702 1.0×	950 2.0×	102 0.5×	177 1.0×	48	2.0k
Oche Agbaji Nigeria	19	1.1k 0.9×	633 0.9×	329 0.7×	382 1.8×	59 0.3×	78	1.5k
Nagalingeswaran Kumarasamy India	25	1.3k 1.1×	617 0.9×	720 1.5×	181 0.8×	73 0.4×	97	1.8k
Patrick Coffié Ivory Coast	20	771 0.6×	630 0.9×	260 0.6×	191 0.9×	59 0.3×	73	1.2k
Albert Minga Ivory Coast	22	1.1k 0.9×	547 0.8×	716 1.5×	137 0.6×	45 0.3×	62	1.4k
George McSherry United States	22	1.6k 1.3×	765 1.1×	821 1.8×	214 1.0×	144 0.8×	52	1.9k
Christiane Welffens-Ekra Ivory Coast	16	928 0.8×	548 0.8×	302 0.6×	548 2.5×	73 0.4×	28	1.3k
Trevor A. Crowell United States	22	945 0.8×	565 0.8×	396 0.8×	262 1.2×	170 1.0×	121	1.6k

Countries citing papers authored by Lerato Mohapi

Since Specialization

Citations

This map shows the geographic impact of Lerato Mohapi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lerato Mohapi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lerato Mohapi more than expected).

Fields of papers citing papers by Lerato Mohapi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lerato Mohapi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lerato Mohapi. The network helps show where Lerato Mohapi may publish in the future.

Co-authorship network of co-authors of Lerato Mohapi

This figure shows the co-authorship network connecting the top 25 collaborators of Lerato Mohapi. A scholar is included among the top collaborators of Lerato Mohapi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lerato Mohapi. Lerato Mohapi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Queiroz, Artur T. L., Amita Gupta, Nikhil Gupte, et al.. (2021). Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV. Frontiers in Immunology. 12. 676980–676980. 10 indexed citations

Munderi, Paula, et al.. (2019). Switching at Low HIV-1 RNA into Fixed Dose Combinations: TDF/FTC/RPV is non-inferior to TDF/FTC/EFV in first-line suppressed patients living with HIV. Southern African Journal of HIV Medicine. 20(1). 949–949. 3 indexed citations

Tweed, Conor, Angela M. Crook, Rodney Dawson, et al.. (2019). Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status. BMC Pulmonary Medicine. 19(1). 152–152.

Moore, Cecilia L., Dianne Carey, Janaki Amin, et al.. (2018). Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy. AIDS. 32(3). 357–361. 3 indexed citations

Tweed, Conor, Genevieve H. Wills, Angela M. Crook, et al.. (2018). Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC Medicine. 16(1). 46–46. 50 indexed citations

Boyd, Mark, Janaki Amin, Patrick Mallon, et al.. (2016). Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. The Lancet HIV. 4(1). e13–e20. 5 indexed citations

Amin, Janaki, Mark Boyd, Nagalingeswaran Kumarasamy, et al.. (2015). Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection. PLoS ONE. 10(2). e0118228–e0118228. 31 indexed citations

Podany, Anthony T., Yajing Bao, Susan Swindells, et al.. (2015). Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention. Clinical Infectious Diseases. 61(8). 1322–1327. 45 indexed citations

Otwombe, Kennedy, Ravindre Panchia, Guy de Bruyn, et al.. (2014). CD4 Counts and Viral Loads of Newly Diagnosed HIV-Infected Individuals: Implications for Treatment as Prevention. PLoS ONE. 9(3). e90754–e90754. 22 indexed citations

10.

Otwombe, Kennedy, et al.. (2013). The Effect of a Maturing Antiretroviral Program on Early Mortality for Patients with Advanced Immune-Suppression in Soweto, South Africa. PLoS ONE. 8(11). e81538–e81538. 7 indexed citations

11.

Boyd, Mark, Nagalingeswaran Kumarasamy, Cecilia L. Moore, et al.. (2013). Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. The Lancet. 381(9883). 2091–2099. 109 indexed citations

12.

Adler, David, Lisa Kakinami, Nkeko Tshabangu, et al.. (2012). Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART. AIDS. 26(13). 1645–1652. 60 indexed citations

13.

Meyer‐Rath, Gesine, Alana T. Brennan, Matthew P. Fox, et al.. (2012). Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(3). 322–328. 34 indexed citations

14.

El‐Khatib, Ziad, David Katzenstein, Gaetano Marrone, et al.. (2011). Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa. PLoS ONE. 6(3). e17518–e17518. 86 indexed citations

15.

Laher, Fatima, Catherine S. Todd, Mark Stibich, et al.. (2010). Role of menstruation in contraceptive choice among HIV-infected women in Soweto, South Africa. Contraception. 81(6). 547–551. 20 indexed citations

16.

Kakinami, Lisa, Guy de Bruyn, Paul Pronyk, et al.. (2010). The Impact of Highly Active Antiretroviral Therapy on Activities of Daily Living in HIV-Infected Adults in South Africa. AIDS and Behavior. 15(4). 823–831. 16 indexed citations

17.

El‐Khatib, Ziad, Anna Mia Ekström, Johanna Ledwaba, et al.. (2010). Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS. 24(11). 1679–1687. 102 indexed citations

18.

Laher, Fatima, et al.. (2009). A Qualitative Assessment of Decisions Affecting Contraceptive Utilization and Fertility Intentions among HIV-Positive Women in Soweto, South Africa. AIDS and Behavior. 13(S1). 47–54. 63 indexed citations

19.

Martinson, Neil, et al.. (2009). Costs of Providing Care for HIV-Infected Adults in an Urban HIV Clinic in Soweto, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(3). 327–330. 36 indexed citations

20.

Golub, Jonathan E., Paul Pronyk, Lerato Mohapi, et al.. (2009). Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 23(5). 631–636. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact